SK284552B6 - Trojvrstvová tableta s riadeným uvoľňovaním účinnej zložky na orálne podávanie - Google Patents

Trojvrstvová tableta s riadeným uvoľňovaním účinnej zložky na orálne podávanie Download PDF

Info

Publication number
SK284552B6
SK284552B6 SK482-2000A SK4822000A SK284552B6 SK 284552 B6 SK284552 B6 SK 284552B6 SK 4822000 A SK4822000 A SK 4822000A SK 284552 B6 SK284552 B6 SK 284552B6
Authority
SK
Slovakia
Prior art keywords
layer
release
pharmaceutical composition
methyl ester
tablet according
Prior art date
Application number
SK482-2000A
Other languages
English (en)
Slovak (sk)
Other versions
SK4822000A3 (en
Inventor
Paolo Chiesi
Paolo Ventura
Daniela Acerbi
Rossella Musa
Ruggero Bettini
Giovanni Caponetti
Pier Luigi Catellani
Original Assignee
Chiesi Farmaceutici S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiesi Farmaceutici S.P.A. filed Critical Chiesi Farmaceutici S.P.A.
Publication of SK4822000A3 publication Critical patent/SK4822000A3/sk
Publication of SK284552B6 publication Critical patent/SK284552B6/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurosurgery (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychology (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
SK482-2000A 1997-10-03 1998-10-01 Trojvrstvová tableta s riadeným uvoľňovaním účinnej zložky na orálne podávanie SK284552B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT97MI002254A IT1295271B1 (it) 1997-10-03 1997-10-03 Monolita contenente uno o piu'farmaci costituito da tre strati a meccanismo di rilascio differenziato
PCT/EP1998/006228 WO1999017745A1 (en) 1997-10-03 1998-10-01 Monolithic system containing one or more drugs, consisting of three layers with different release mechanisms

Publications (2)

Publication Number Publication Date
SK4822000A3 SK4822000A3 (en) 2000-09-12
SK284552B6 true SK284552B6 (sk) 2005-06-02

Family

ID=11377984

Family Applications (1)

Application Number Title Priority Date Filing Date
SK482-2000A SK284552B6 (sk) 1997-10-03 1998-10-01 Trojvrstvová tableta s riadeným uvoľňovaním účinnej zložky na orálne podávanie

Country Status (14)

Country Link
EP (1) EP1019029B1 (hu)
AR (1) AR043070A1 (hu)
AT (1) ATE248590T1 (hu)
AU (1) AU9629198A (hu)
BR (1) BR9815248A (hu)
CZ (1) CZ298851B6 (hu)
DE (1) DE69817848T2 (hu)
ES (1) ES2205558T3 (hu)
HU (1) HU225692B1 (hu)
IT (1) IT1295271B1 (hu)
NO (1) NO20001709L (hu)
SK (1) SK284552B6 (hu)
WO (1) WO1999017745A1 (hu)
ZA (1) ZA989010B (hu)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003041646A2 (en) 2001-11-13 2003-05-22 Teva Pharmaceutical Industries, Ltd. L-dopa ethyl ester salts and uses thereof
US20030224045A1 (en) * 2002-05-29 2003-12-04 Chien-Hsuan Han Combination immediate release sustained release levodopa/carbidopa dosage forms
US7094427B2 (en) * 2002-05-29 2006-08-22 Impax Laboratories, Inc. Combination immediate release controlled release levodopa/carbidopa dosage forms
CA2613631A1 (en) * 2005-06-23 2007-01-04 Spherics, Inc. Improved dosage forms for movement disorder treatment
WO2007073702A2 (es) * 2005-12-29 2007-07-05 Osmotica Corp. Comprimido multicapa con combinación de triple liberación
BRPI0917444A2 (pt) 2008-08-15 2015-12-01 Depomed Inc composições farmacêuticas de retenção gástrica para o tratamento e prevenção de doenas do snc
WO2011124953A2 (en) * 2010-04-07 2011-10-13 Lupin Limited Controlled release pharmaceutical compositions of tapentadol
EP2508174A1 (en) 2011-04-06 2012-10-10 Ljiljana Sovic Brkicic Pharmaceutical composition
US20130143867A1 (en) 2011-12-02 2013-06-06 Sychroneuron Inc. Acamprosate formulations, methods of using the same, and combinations comprising the same
ITMI20121263A1 (it) * 2012-07-19 2014-01-20 Recordati Ind Chimica E Farma Ceutica S P A Forma farmaceutica multistrato
JP2016520653A (ja) 2013-06-05 2016-07-14 シンクロニューロン インコーポレイテッド アカンプロサート製剤、それを用いる方法、およびそれを含む合剤
EP3054929B1 (en) 2013-10-07 2020-08-05 Impax Laboratories, LLC Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof
US10987313B2 (en) 2013-10-07 2021-04-27 Impax Laboratories, Llc Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof
GB201506755D0 (en) 2015-04-21 2015-06-03 Reckitt Benckiser Llc Novel pharmaceutical formulation
US9808478B2 (en) * 2015-04-17 2017-11-07 Steven Loyd Control release of fat soluble antioxidants from an oral formulation and method
EP3364955B1 (en) 2015-10-09 2022-04-20 RB Health (US) LLC Pharmaceutical formulation
US11986449B2 (en) 2020-12-22 2024-05-21 Amneal Pharmaceuticals Llc Levodopa dosing regimen

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1255522B (it) * 1992-09-24 1995-11-09 Ubaldo Conte Compressa per impiego terapeutico atta a cedere una o piu' sostanze attive con differenti velocita'
IT1256393B (it) * 1992-11-17 1995-12-04 Inverni Della Beffa Spa Forme matriciali multistrato per il rilascio controllato di principi attivi
IT1264696B1 (it) * 1993-07-09 1996-10-04 Applied Pharma Res Forme farmaceutiche destinate alla somministrazione orale in grado di rilasciare sostanze attive a velocita' controllata e differenziata
IT1282576B1 (it) * 1996-02-06 1998-03-31 Jagotec Ag Compressa farmaceutica atta a cedere la sostanza attiva in tempi successivi e predeterminabili

Also Published As

Publication number Publication date
ZA989010B (en) 1999-04-12
AR043070A1 (es) 2005-07-20
WO1999017745A1 (en) 1999-04-15
AU9629198A (en) 1999-04-27
EP1019029A1 (en) 2000-07-19
HUP0004015A2 (hu) 2001-08-28
IT1295271B1 (it) 1999-05-04
HUP0004015A3 (en) 2006-06-28
BR9815248A (pt) 2000-11-21
CZ298851B6 (cs) 2008-02-27
CZ20001200A3 (cs) 2000-09-13
NO20001709L (no) 2000-06-05
ES2205558T3 (es) 2004-05-01
ITMI972254A1 (it) 1999-04-03
DE69817848D1 (de) 2003-10-09
SK4822000A3 (en) 2000-09-12
NO20001709D0 (no) 2000-04-03
EP1019029B1 (en) 2003-09-03
ATE248590T1 (de) 2003-09-15
HU225692B1 (en) 2007-06-28
DE69817848T2 (de) 2005-04-07

Similar Documents

Publication Publication Date Title
RU2385712C2 (ru) Рецептура с контролируемым высвобождением
JP4758064B2 (ja) 有効物質を徐放する３−（３−ジメチルアミノ−１−エチル−２−メチル−プロピル）フェノール含有医薬
DK2204168T3 (en) Tetracycline for administration once a day
US7915247B1 (en) Methods of use of fenofibric acid
RU2616516C2 (ru) Фармацевтическая композиция, содержащая олмесартана медоксомил и розувастатин или его соль
KR20210016416A (ko) 글루코키나제 활성화제 및 dpp-iv 억제제를 포함하는 약제학적 병용물, 조성물 및 병용 제제, 및 이의 제조 방법 및 용도
US20060127478A1 (en) Oral dosage formulation
US20090124702A1 (en) Pharmaceutical Compositions of Metformin
SK284552B6 (sk) Trojvrstvová tableta s riadeným uvoľňovaním účinnej zložky na orálne podávanie
WO2009034541A9 (en) Controlled release pharmaceutical dosage forms of trimetazidine
SK30396A3 (en) Beads, method for producing them and a pharmaceutical preparation containing the same
ZA200703810B (en) Dosage form time-lagged of drugs for the therapy of insomnia
KR20090091085A (ko) 방출성이 제어된 약제학적 제제
WO2021129735A1 (zh) 一种固体制剂及其制备方法和用途
JP2005508901A (ja) 活性成分を徐放する剤形
WO2004096182A1 (en) Extended release matrix tablets of carvedilol
EA030466B1 (ru) Фармацевтическая композиция, обладающая улучшенной стабильностью
HU221590B (hu) Béta-fenil-propiofenon-származékokat tartalmazó retard mikrotabletták
KR20090091075A (ko) 심혈관계 질환 치료용 약제학적 제제
AU2014295098B2 (en) Anti-tuberculosis stable pharmaceutical composition in a form of a coated tablet comprising granules of isoniazid and granules of rifapentine and its process of preparation
JPH08333259A (ja) スクラルファート含有製剤組成物
EP2010158B1 (en) Controlled release formulations comprising uncoated discrete unit(s) and an extended release matrix
KR20160105662A (ko) 에페리손과 펠루비프로펜을 함유하는 약제학적 조성물
JPH1121233A (ja) マルチプルユニットタイプ徐放性錠剤
SK11072000A3 (sk) Tiagabínové prostriedky s predĺženým uvoľňovaním so zníženými vedľajšími účinkami